Lupron depot 3.75 MG kits
Ended Awarded Last action
- Contract number
- SPE2DR26FG3QA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,087
Award facts
- Contract value 100% obligated
- $25,087.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.48 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 3.75 mg kits. This competitively awarded, firm fixed-price contract was executed on January 20, 2026, with an ultimate completion date of January 21, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999.99 million and extends through December 2031, serving as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
Lupron Depot is a hormone therapy medication commonly used in oncology and urology treatments. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical and medical supply deliveries. The company's federal contract awards consistently involve competitively bid, firm fixed-price delivery orders across multiple therapeutic domains, demonstrating its capability to efficiently fulfill government requirements for essential pharmaceutical commodities supporting military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FG3QA?
SPE2DR26FG3QA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FG3QA worth?
The government has obligated $25,087 on SPE2DR26FG3QA.
Is contract SPE2DR26FG3QA an order under another contract?
Yes. SPE2DR26FG3QA is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3QA competed?
The extent of competition for SPE2DR26FG3QA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award